US$ 20.46
does medicare cover any glp 1 drugs covers GLP-1s to treat diabetes and some other health conditions, including obstructive sleep apnea and cardiovascular disease, but not obesity Recent Trends in GLP-1 Use
Description
Statistical analysis We did not perform power calculations, but the sample size and animal number for each group were chosen based on study feasibility and prior knowledge of statistical power from previously published experiments

Preliminary data suggests fewer than 30% of patients are still on an AOM after 1 year, with abandonment and discontinuation rates highly sensitive to costs
doi: 10.4158/EP11097.OR

The institute recommended that existing GLP-1 makers, and those with products in the pipeline, should consider steep discounts to prices in exchange for higher volume. What has to happen is we have to move from a low-volume, high-price business model, to a high-volume, low-price business model, Nunn said
[DOI] [PubMed] [Google Scholar] 562.Villareal D.T., Robertson H., Bell G.I., Patterson B.W., Tran H., Wice B
